Head and neck pathology · 2026
Oral Melanoma: A South American Collaborative Series of 21 Cases.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
de Arruda José Alcides Almeida, Villarroel-Dorrego Mariana, Peña-Vega Claudia Patricia, Rodríguez-Mora Juan Pablo, Gilligan Gerardo, Panico René, Gimenez Javier, Flück Verónica, Castrillo Ángeles, Scalise Georgina, Leguina Laura, Monteiro Mariene da Silva, Sampaio Gerhilde Callou, Drumond Victor Zanetti, Tenório Jefferson R, de Andrade Bruno Augusto Benevenuto
Аннотация
BACKGROUND: Oral melanoma is a rare and aggressive malignant neoplasm that typically exhibits variable degrees of pigmentation. Amelanotic variants further complicate clinical diagnosis by mimicking non-neoplastic lesions. The present study aimed to describe the clinicopathological characteristics, management, and outcomes of oral melanoma in South America.
METHODS: This collaborative retrospective study included cases diagnosed between 2003 and 2025 from five oral pathology and oral medicine centers in Argentina, Venezuela, Colombia, and Brazil. Clinicopathological, treatment, and follow-up data were analyzed descriptively.
RESULTS: Twenty-one cases of primary oral melanoma were analyzed. The mean age was 63.0 years, with a slight female predominance (52.4%). Most lesions were asymptomatic at diagnosis (78.3%) and involved the palate/maxillary gingiva (66.7%). Clinically, tumors (37.9%) and macules (27.6%) were the most frequent presentations. Histologically, melanotic melanoma predominated (76.2%). Melan-A, HMB-45, SOX10, and S-100 protein were the most frequently used immunohistochemical markers. Surgical resection was performed in 85.7% of cases. During follow-up, 52.6% of patients died.
CONCLUSION: Data corroborate the clinicopathological profile of oral melanoma and expand current knowledge by documenting novel South American cases, underscoring its marked clinical heterogeneity, poor prognosis, and the critical importance of early recognition.
METHODS: This collaborative retrospective study included cases diagnosed between 2003 and 2025 from five oral pathology and oral medicine centers in Argentina, Venezuela, Colombia, and Brazil. Clinicopathological, treatment, and follow-up data were analyzed descriptively.
RESULTS: Twenty-one cases of primary oral melanoma were analyzed. The mean age was 63.0 years, with a slight female predominance (52.4%). Most lesions were asymptomatic at diagnosis (78.3%) and involved the palate/maxillary gingiva (66.7%). Clinically, tumors (37.9%) and macules (27.6%) were the most frequent presentations. Histologically, melanotic melanoma predominated (76.2%). Melan-A, HMB-45, SOX10, and S-100 protein were the most frequently used immunohistochemical markers. Surgical resection was performed in 85.7% of cases. During follow-up, 52.6% of patients died.
CONCLUSION: Data corroborate the clinicopathological profile of oral melanoma and expand current knowledge by documenting novel South American cases, underscoring its marked clinical heterogeneity, poor prognosis, and the critical importance of early recognition.